Benjamin Looker, General Counsel at Trillium Therapeutics, holds ― shares in Trillium Therapeutics (Ticker: TRIL), holds 183.66K shares in Esperion (Ticker: ESPR). Most recently, Benjamin Looker ― shares of Trillium Therapeutics on ― for an estimated value of ―.